Aurobindo Pharma Limited has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Olopatadine Hydrochloride Ophthalmic Solution USP, 0.1% which makes the product is ready for launch. 106 more words
Tags » Alcon Laboratories
SACRAMENTO (CBS13) — District attorneys from five California counties are joining in a slack-fill lawsuit against two pharmaceutical companies.
Novartis Pharmaceuticals Corporation and Alcon Laboratories are accused of misleading consumers on the packing of their products. 143 more words
ALLEGAN — Perrigo Co. (Nasdaq: PRGO) announced that it has filed with the U.S. Food and Drug Administration an Abbreviated New Drug Application for olopatadine hydrochloride nasal spray and that it has notified Alcon Laboratories, the owner of the New Drug Application (NDA). 234 more words